Boston Scientific (BSX) announces agreement to acquire Penumbra (PEN) for USD 374/shr and deal values PEN at USD 14.5bln

Boston Scientific's acquisition of Penumbra for $14.5 billion at $374 per share indicates a strategic move to enhance its portfolio in the healthcare equipment sector.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

German authorities search private properties in connection with Baywa (BYW GY), Sueddeutsche reports

Revolut, Visa (V) and Mastercard (MA) lose legal challenge over fee cap, FT reports

Boston Scientific (BSX) announces agreement to acquire Penumbra (PEN) for USD 374/shr and deal values PEN at USD 14.5bln

Iranian Official says US President Trump informed Iran he does not intend to attack, via Dawn

French President Macron aims to strengthen the military with a EUR 36bln increase in spending by 2030, including a EUR 3.5bln increase for 2026

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This deal may prompt a reevaluation of valuations within the healthcare space and could impact investor sentiment towards both firms, as well as raise questions regarding potential regulatory scrutiny in future mergers.

Related headlines

The whole workspace, free to try.

Try it free